What Is Diatomite? Properties, Filtration Uses and Industrial Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Diatomaceous Earth? Composition, Grades and Common Uses
  • Keywords: is silicon dioxide acidic
  • Published: 2026-11-20 00:41:56
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Ultrafine Silica Powder: Particle Sizes, Specifications and Applications

Silica Bulk Density: Typical Values by Type and Why It Matters for Handling
where M t is the volume of drug released at time t; M 0 is the opening amount of drug; D is the diffusion coefficient in the matrix; and h is the thickness of the system.
Silica Supplier Japan: Leading Producers and High-Purity Sourcing Options
78. Guo X., Zhang C., Bai Y., Che Q., Cao H., Guo J., Su Z. Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury. Molecules. 2023;28:4147. doi: 10.3390/molecules28104147. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
What Is Highly Dispersible Silica (HDS)? Benefits for Tire Performance Explained
Quechen Silica: Company Overview, Product Range and Applications

Nouryon Levasil: Colloidal Silica Product Range and Applications

What is silica (SiO₂)?

wollastonite

What is the difference between fumed silica and precipitated silica?

silica tapped density Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].

What drives silica raw material prices?

rheology modifier silica This equation fits especially well for premature release, up to 60% of the drug released, when there is no change in the matrix system during the release process. From a perspective of pore geometry, it basically controls drug release rates by affecting effective diffusion pathways. Boosted complexity of geometries raises tortuosity and reduces effective diffusion. High tortuosity and low pore connectivity cut down drug diffusion, consequently lowering the release rates. Furthermore, surface roughness and pore size distribution affect surface region, diffusion, and residence times, and thereby drug release kinetics. Thus, coupling the Fick diffusion model with parameters characterizing pore geometry (e.g., porosity, tortuosity, etc.) enables for more precise and automatic modeling of drug release kinetics. In this way, it is nicely clarified why release profiles differ for chemically comparable matrices due to differences in their geometrical shapes [ 59, 60 ].

Cite this article: Silica Raw Materials News. "Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses ." Published 2026-11-20 00:41:56. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.